To address America’s drug pricing problem, state policymakers face myriad conflicts and trade-offs, inadequate information about the “black box” of drug pricing, and an uncertain road map for how best to address the issue. This NASHP guest report, published in the September 2019 edition of the Journal of Legal Medicine, provides an overview of challenges states face in lowering drug costs as well as a number of innovative solutions including pharmacy benefit manager oversight, wholesale drug importation, anti-price gouging laws, drug affordability review boards, and Medicaid initiatives.
Read: States on the Front Line: Addressing America’s Drug Pricing Problem
